| 13.22 -0.35 (-2.58%) | 11-18 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 17.13 | 1-year : | 18.67 |
| Resists | First : | 14.66 | Second : | 15.98 |
| Pivot price | 13.74 |
|||
| Supports | First : | 12.52 | Second : | 10.42 |
| MAs | MA(5) : | 13.26 |
MA(20) : | 13.86 |
| MA(100) : | 16.22 |
MA(250) : | 18.14 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 34.2 |
D(3) : | 30.8 |
| RSI | RSI(14): 40.5 |
|||
| 52-week | High : | 23.59 | Low : | 12.52 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ USNA ] has closed above bottom band by 29.5%. Bollinger Bands are 31.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.7 - 13.77 | 13.77 - 13.83 |
| Low: | 12.99 - 13.07 | 13.07 - 13.12 |
| Close: | 13.11 - 13.23 | 13.23 - 13.32 |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Fri, 13 Nov 2026
USNA - USANA Health Sciences, Inc. | News - OTC Markets
Thu, 12 Nov 2026
USANA Health Sciences (USNA) Stock Falls on Q3 2026 Earnings - Quiver Quantitative
Tue, 03 Nov 2026
USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Wed, 05 Aug 2026
USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade) (NYSE:USNA) - Seeking Alpha
Tue, 04 Aug 2026
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Tue, 28 Jul 2026
How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 18 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 40.9 (%) |
| Held by Institutions | 60.2 (%) |
| Shares Short | 779 (K) |
| Shares Short P.Month | 755 (K) |
| EPS | -1.14 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.47 |
| Profit Margin | -2.4 % |
| Operating Margin | -0.7 % |
| Return on Assets (ttm) | 3.3 % |
| Return on Equity (ttm) | -5.2 % |
| Qtrly Rev. Growth | -3.6 % |
| Gross Profit (p.s.) | 37.86 |
| Sales Per Share | 49 |
| EBITDA (p.s.) | 3.8 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -11.6 |
| PEG Ratio | 0.6 |
| Price to Book value | 0.46 |
| Price to Sales | 0.26 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |